Patent intelligence · US
US 10927124
Compounds and compositions and uses thereof
Compounds and compositions and uses thereof
Patent details — US 10927124
- Jurisdiction
- US
- Status
- granted
- Grant date
- Feb 23, 2021
- Expiration
- Feb 18, 2041
- Applicant
- PGI Drug Discovery LLC
- Claims
- 26
- CPC classes
- A61P, A61P25/14, A61P25/18, A61P25/28
Quick answer
US 10927124 (Compounds and compositions and uses thereof) is held by PGI Drug Discovery LLC. Status: granted. Granted Feb 23, 2021. Expires Feb 18, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- PGI Drug Discovery LLC
- Grant date
- Expiration
- Claims
- 26
- CPC classes
- A61P, A61P25/14, A61P25/18, A61P25/28
More from PGI Drug Discovery LLC
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 10927124?
US 10927124 (Compounds and compositions and uses thereof) is held by PGI Drug Discovery LLC. Status: granted. Granted Feb 23, 2021. Expires Feb 18, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10927124?
PGI Drug Discovery LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 10927124 expire?
Our index shows an expiration date of Feb 18, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.